Tarina Fe 1/20 EQ NDC 50102-228

NDC codes

FDA NDC Directory

Product NDC (as listed)50102-228Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50102-0228Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50102-228-23	50102022823	3 POUCH in 1 CARTON (50102-228-23) / 1 BLISTER PACK in 1 POUCH (50102-228-21) / 1 KIT in 1 BLISTER PACKMarketed from Jun 16, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tarina Fe 1/20 EQ
Generic name (nonproprietary): norethindrone acetate and ethinyl estradiol and ferrous fumarate
Dosage form: Kit
Labeler: Afaxys Pharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207505
Marketing start: Jun 16, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 50102-228_4daddb44-fa57-496e-9c83-67cb3ceeafb7SPL ID 4daddb44-fa57-496e-9c83-67cb3ceeafb7SPL set ID ed7dd100-a339-41bc-91be-6d20b73dbce6RxCUI 259176, 1358762, 1358763, 1550536

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N450102022823 followed by a unit qualifier and the quantity

Package 50102-0228-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 21, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Tarina Fe 1/20 EQ is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE 1 LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHOD % of Women Experiencing an Unintended Pregnancy in the First Year …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207505

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207505
Product	Strength	Form · route	Labeler	Product NDC
Aurovela Fe 1/20norethindrone acetate and ethinyl estradiol and ferrous fumarate	—	Kit	Aurobindo Pharma Limited	65862-940